Literature DB >> 3058125

Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells.

A M Craig1, M Nemir, B B Mukherjee, A F Chambers, D T Denhardt.   

Abstract

/ar, a tumor promoter-inducible protein secreted by mouse JB6 epidermal cells, is the murine homolog of rat osteopontin, or 44 kD bone phosphoprotein. We report here that 2ar is also related to pp69, a major phosphoprotein secreted by normal rat kidney cells. Antisera raised against pp69 and against beta-galactosidase-2ar fusion proteins are able to immunoprecipitate the same major phosphoproteins, of apparent Mr 55-69 kD, secreted by several rat and mouse cell lines. The levels of secreted protein and cytoplasmic mRNA are dramatically elevated in NIH 3T3 cells transformed with the human bladder cancer T24 (H-ras) oncogene. These results and the work of Senger and colleagues (Cancer Res., 45, 5818-5823, 1985) imply that enhanced secretion of 2ar/pp69/osteopontin by transformation of a wide variety of mammalian fibroblasts and epithelial cells is often correlated with tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058125     DOI: 10.1016/s0006-291x(88)80028-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer.

Authors:  Guoxin Zhang; Bin He; Georg F Weber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

2.  Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.

Authors:  H Shiraga; W Min; W J VanDusen; M D Clayman; D Miner; C H Terrell; J R Sherbotie; J W Foreman; C Przysiecki; E G Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

3.  Loss of tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.

Authors:  K Adam Morrow; Shamik Das; Brandon J Metge; Keqiang Ye; Madhuri S Mulekar; J Allan Tucker; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

4.  Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals.

Authors:  Amanda Brown; Tanzeem Islam; Robert Adams; Sujata Nerle; Masiray Kamara; Caitlin Eger; Karen Marder; Bruce Cohen; Giovanni Schifitto; Justin C McArthur; Ned Sacktor; Carlos A Pardo
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

5.  Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression.

Authors:  M Noda; R L Vogel; A M Craig; J Prahl; H F DeLuca; D T Denhardt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.

Authors:  C M Giachelli; N Bae; M Almeida; D T Denhardt; C E Alpers; S M Schwartz
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

7.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells.

Authors:  K Nasu; T Ishida; M Setoguchi; Y Higuchi; S Akizuki; S Yamamoto
Journal:  Biochem J       Date:  1995-04-01       Impact factor: 3.857

9.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Nonclassical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting Hedgehog inhibition.

Authors:  Shamik Das; Rajeev S Samant; Lalita A Shevde
Journal:  J Biol Chem       Date:  2013-03-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.